Related Experiment Video
Updated: Jun 3, 2026
11:00
Reliable Acquisition of Electroencephalography Data during Simultaneous Electroencephalography and Functional MRI
Published on: March 19, 2021
[Epilepsy guidelines: Japanese and international guidelines]
Naoki Akamatsu1, Sadatoshi Tsuji
1Department of Neurology, University of Occupational and Environmental Health, School of Medicine, Iseigaoka, Yahatanishi-ku, Kitakyusyu, Japan.
Brain and Nerve = Shinkei Kenkyu No Shinpo
|March 29, 2011
Summary
New Japanese clinical guidelines for epilepsy management offer practical advice for general practitioners. These evidence-based recommendations cover diagnosis, treatment, and social aspects of epilepsy care.
Area of Science:
- Neurology
- Evidence-Based Medicine
Context:
- Previous epilepsy management guidelines in Japan were published by the Japanese Society of Neurology (JSN) in 2002 and the Japan Epilepsy Society (JES) in 2005.
- Advances in epileptology necessitated a revision and consolidation of existing guidelines.
Purpose:
- To provide updated, comprehensive, and user-friendly clinical guidelines for epilepsy management in Japan.
- To consolidate expertise from four major neurological societies into a single, practical resource.
Summary:
- Four Japanese medical societies collaborated to publish new clinical guidelines for epilepsy management in October 2010.
- These guidelines address 81 clinical questions (CQs) covering diagnosis, treatment, surgery, pregnancy, and social issues.
- Recommendations are graded (A-D) based on evidence levels (I-IV) from a thorough literature review.
Impact:
- Aims to assist general practitioners in the effective management of epilepsy patients.
- Enhances the standardization and quality of epilepsy care across Japan.
- Serves as a crucial reference for practitioners dealing with diverse epilepsy-related challenges.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...